在视网膜神经纤维层变薄与12年痴呆之间的关系中,APOE ε4非依赖性通路占主导地位

IF 4.9 Q1 CLINICAL NEUROLOGY
Yuzhuo Wang, Xiaoxi Ma, Haoze Cen, Jie Wang, Jie Wu, Ding Ding, Yiqin Xiao, Qianhua Zhao
{"title":"在视网膜神经纤维层变薄与12年痴呆之间的关系中,APOE ε4非依赖性通路占主导地位","authors":"Yuzhuo Wang,&nbsp;Xiaoxi Ma,&nbsp;Haoze Cen,&nbsp;Jie Wang,&nbsp;Jie Wu,&nbsp;Ding Ding,&nbsp;Yiqin Xiao,&nbsp;Qianhua Zhao","doi":"10.1002/trc2.70104","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> INTRODUCTION</h3>\n \n <p>Emerging evidence links retinal nerve fiber layer (RNFL) thinning to cognitive impairment, while the apolipoprotein E (<i>APOE</i>) ε4 allele, the key genetic dementia risk factor, is also found to be associated with RNFL thickness. This study investigated the longitudinal association between RNFL thinning and 12-year dementia risk, evaluated the role of <i>APOE</i> ε4 in this relationship, and clarified the independent value of retinal imaging as a predictive biomarker for dementia.</p>\n </section>\n \n <section>\n \n <h3> METHODS</h3>\n \n <p>This study included 35,433 participants from the UK Biobank. Generalized linear models and Jonckheere-Terpstra tests assessed the association between <i>APOE</i> ε4 allele dosage and macular RNFL (mRNFL) thickness. Cox models evaluated the association between mRNFL thickness and incident dementia. To address potential confounding by <i>APOE</i> ε4, inverse probability weighting was applied. Mediation analysis quantified the contribution of <i>APOE</i> pathways to the mRNFL-dementia association.</p>\n </section>\n \n <section>\n \n <h3> RESULTS</h3>\n \n <p>Among 35,433 participants, 392 (1.11%) developed dementia over a median follow-up of 12.49 years (interquartile range: 12.39 to 12.64). <i>APOE</i> ε4 carriers exhibited a dose-dependent reduction in mRNFL thickness (β = −0.14, 95% confidence interval [CI]: −0.23 to −0.05, <i>p</i> = 0.002). After adjusting for age, sex, vascular risk factors, and <i>APOE</i> ε4 carrier status, the lowest mRNFL quintile group had a 64% higher dementia risk compared to the highest quintile (hazard ratio [HR] = 1.64, 95% CI: 1.17 to 2.30, <i>p</i> = 0.004). Each 5-µm reduction in mRNFL thickness corresponded to a 15% increased risk (HR = 1.15, 95% CI: 1.02 to 1.30, <i>p</i> = 0.02), which remained significant after inverse probability weighting. Mediation analysis revealed that <i>APOE</i> pathways accounted for 7.6% (95% CI: 2.6% to 28.6%, <i>p</i> = 0.01) of the mRNFL-dementia association.</p>\n </section>\n \n <section>\n \n <h3> DISCUSSION</h3>\n \n <p>Our findings resolve a controversy by showing that while <i>APOE</i> ε4 accelerates mRNFL degeneration, retinal imaging captures dementia-related neuropathology through pathways distinct from direct <i>APOE</i> effects, solidifying its potential as an etiologically informative biomarker.</p>\n </section>\n \n <section>\n \n <h3> Highlights</h3>\n \n <div>\n <ul>\n \n <li>The association between <i>APOE</i> ε4 carriers and thinner RNFL was solidified by the J-T test and multiple linear regression, indicating genetic influence on retinal structure.</li>\n \n <li>After inverse probability weighting adjustment, each 5-µm reduction in baseline RNFL thickness increased dementia risk by 15%, highlighting its long-term predictive value.</li>\n \n <li>Only 7.6% of the effect of RNFL thickness on dementia risk was attributable to <i>APOE</i> status, underscoring the value of RNFL as a standalone, non-invasive biomarker in the assessment of long-term dementia risk.</li>\n </ul>\n </div>\n </section>\n </div>","PeriodicalId":53225,"journal":{"name":"Alzheimer''s and Dementia: Translational Research and Clinical Interventions","volume":"11 2","pages":""},"PeriodicalIF":4.9000,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/trc2.70104","citationCount":"0","resultStr":"{\"title\":\"APOE ε4-independent pathways predominate in the association between retinal nerve fiber layer thinning and 12-year incident dementia\",\"authors\":\"Yuzhuo Wang,&nbsp;Xiaoxi Ma,&nbsp;Haoze Cen,&nbsp;Jie Wang,&nbsp;Jie Wu,&nbsp;Ding Ding,&nbsp;Yiqin Xiao,&nbsp;Qianhua Zhao\",\"doi\":\"10.1002/trc2.70104\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> INTRODUCTION</h3>\\n \\n <p>Emerging evidence links retinal nerve fiber layer (RNFL) thinning to cognitive impairment, while the apolipoprotein E (<i>APOE</i>) ε4 allele, the key genetic dementia risk factor, is also found to be associated with RNFL thickness. This study investigated the longitudinal association between RNFL thinning and 12-year dementia risk, evaluated the role of <i>APOE</i> ε4 in this relationship, and clarified the independent value of retinal imaging as a predictive biomarker for dementia.</p>\\n </section>\\n \\n <section>\\n \\n <h3> METHODS</h3>\\n \\n <p>This study included 35,433 participants from the UK Biobank. Generalized linear models and Jonckheere-Terpstra tests assessed the association between <i>APOE</i> ε4 allele dosage and macular RNFL (mRNFL) thickness. Cox models evaluated the association between mRNFL thickness and incident dementia. To address potential confounding by <i>APOE</i> ε4, inverse probability weighting was applied. Mediation analysis quantified the contribution of <i>APOE</i> pathways to the mRNFL-dementia association.</p>\\n </section>\\n \\n <section>\\n \\n <h3> RESULTS</h3>\\n \\n <p>Among 35,433 participants, 392 (1.11%) developed dementia over a median follow-up of 12.49 years (interquartile range: 12.39 to 12.64). <i>APOE</i> ε4 carriers exhibited a dose-dependent reduction in mRNFL thickness (β = −0.14, 95% confidence interval [CI]: −0.23 to −0.05, <i>p</i> = 0.002). After adjusting for age, sex, vascular risk factors, and <i>APOE</i> ε4 carrier status, the lowest mRNFL quintile group had a 64% higher dementia risk compared to the highest quintile (hazard ratio [HR] = 1.64, 95% CI: 1.17 to 2.30, <i>p</i> = 0.004). Each 5-µm reduction in mRNFL thickness corresponded to a 15% increased risk (HR = 1.15, 95% CI: 1.02 to 1.30, <i>p</i> = 0.02), which remained significant after inverse probability weighting. Mediation analysis revealed that <i>APOE</i> pathways accounted for 7.6% (95% CI: 2.6% to 28.6%, <i>p</i> = 0.01) of the mRNFL-dementia association.</p>\\n </section>\\n \\n <section>\\n \\n <h3> DISCUSSION</h3>\\n \\n <p>Our findings resolve a controversy by showing that while <i>APOE</i> ε4 accelerates mRNFL degeneration, retinal imaging captures dementia-related neuropathology through pathways distinct from direct <i>APOE</i> effects, solidifying its potential as an etiologically informative biomarker.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Highlights</h3>\\n \\n <div>\\n <ul>\\n \\n <li>The association between <i>APOE</i> ε4 carriers and thinner RNFL was solidified by the J-T test and multiple linear regression, indicating genetic influence on retinal structure.</li>\\n \\n <li>After inverse probability weighting adjustment, each 5-µm reduction in baseline RNFL thickness increased dementia risk by 15%, highlighting its long-term predictive value.</li>\\n \\n <li>Only 7.6% of the effect of RNFL thickness on dementia risk was attributable to <i>APOE</i> status, underscoring the value of RNFL as a standalone, non-invasive biomarker in the assessment of long-term dementia risk.</li>\\n </ul>\\n </div>\\n </section>\\n </div>\",\"PeriodicalId\":53225,\"journal\":{\"name\":\"Alzheimer''s and Dementia: Translational Research and Clinical Interventions\",\"volume\":\"11 2\",\"pages\":\"\"},\"PeriodicalIF\":4.9000,\"publicationDate\":\"2025-05-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/trc2.70104\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Alzheimer''s and Dementia: Translational Research and Clinical Interventions\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/trc2.70104\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alzheimer''s and Dementia: Translational Research and Clinical Interventions","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/trc2.70104","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

新的证据表明视网膜神经纤维层(RNFL)变薄与认知障碍有关,而载脂蛋白E (APOE) ε4等位基因是痴呆症的关键遗传危险因素,也被发现与RNFL厚度有关。本研究探讨了RNFL变薄与12年痴呆风险之间的纵向关联,评估了APOE ε4在这一关系中的作用,并阐明了视网膜成像作为痴呆预测生物标志物的独立价值。方法:本研究纳入来自UK Biobank的35,433名参与者。广义线性模型和Jonckheere-Terpstra检验评估APOE ε4等位基因剂量与黄斑RNFL (mRNFL)厚度的关系。Cox模型评估了mRNFL厚度与痴呆发生率之间的关系。为了解决APOE ε4可能造成的混淆,采用了逆概率加权。中介分析量化了APOE途径对mrnfl -痴呆关联的贡献。结果:在35,433名参与者中,392名(1.11%)在中位随访12.49年(四分位数范围:12.39至12.64)期间发生痴呆。APOE ε4携带者mRNFL厚度呈剂量依赖性降低(β = - 0.14, 95%可信区间[CI]: - 0.23 ~ - 0.05, p = 0.002)。在调整了年龄、性别、血管危险因素和APOE ε4携带者状态后,mRNFL最低五分位数组的痴呆风险比最高五分位数组高64%(风险比[HR] = 1.64, 95% CI: 1.17 ~ 2.30, p = 0.004)。mRNFL厚度每减少5µm,风险增加15% (HR = 1.15, 95% CI: 1.02至1.30,p = 0.02),在逆概率加权后仍然显著。中介分析显示,APOE通路占mrnfl -痴呆关联的7.6% (95% CI: 2.6%至28.6%,p = 0.01)。我们的研究结果解决了一个争议,表明虽然APOE ε4加速mRNFL变性,但视网膜成像通过不同于APOE直接作用的途径捕获痴呆相关的神经病理,巩固了其作为病因信息性生物标志物的潜力。J-T检验和多元线性回归证实了APOE ε4携带者与较薄RNFL之间的关系,表明遗传对视网膜结构有影响。在逆概率加权调整后,基线RNFL厚度每减少5µm,痴呆风险增加15%,突出了其长期预测价值。只有7.6%的RNFL厚度对痴呆风险的影响可归因于APOE状态,强调了RNFL作为独立的、非侵入性的生物标志物在评估长期痴呆风险中的价值。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
APOE ε4-independent pathways predominate in the association between retinal nerve fiber layer thinning and 12-year incident dementia

INTRODUCTION

Emerging evidence links retinal nerve fiber layer (RNFL) thinning to cognitive impairment, while the apolipoprotein E (APOE) ε4 allele, the key genetic dementia risk factor, is also found to be associated with RNFL thickness. This study investigated the longitudinal association between RNFL thinning and 12-year dementia risk, evaluated the role of APOE ε4 in this relationship, and clarified the independent value of retinal imaging as a predictive biomarker for dementia.

METHODS

This study included 35,433 participants from the UK Biobank. Generalized linear models and Jonckheere-Terpstra tests assessed the association between APOE ε4 allele dosage and macular RNFL (mRNFL) thickness. Cox models evaluated the association between mRNFL thickness and incident dementia. To address potential confounding by APOE ε4, inverse probability weighting was applied. Mediation analysis quantified the contribution of APOE pathways to the mRNFL-dementia association.

RESULTS

Among 35,433 participants, 392 (1.11%) developed dementia over a median follow-up of 12.49 years (interquartile range: 12.39 to 12.64). APOE ε4 carriers exhibited a dose-dependent reduction in mRNFL thickness (β = −0.14, 95% confidence interval [CI]: −0.23 to −0.05, p = 0.002). After adjusting for age, sex, vascular risk factors, and APOE ε4 carrier status, the lowest mRNFL quintile group had a 64% higher dementia risk compared to the highest quintile (hazard ratio [HR] = 1.64, 95% CI: 1.17 to 2.30, p = 0.004). Each 5-µm reduction in mRNFL thickness corresponded to a 15% increased risk (HR = 1.15, 95% CI: 1.02 to 1.30, p = 0.02), which remained significant after inverse probability weighting. Mediation analysis revealed that APOE pathways accounted for 7.6% (95% CI: 2.6% to 28.6%, p = 0.01) of the mRNFL-dementia association.

DISCUSSION

Our findings resolve a controversy by showing that while APOE ε4 accelerates mRNFL degeneration, retinal imaging captures dementia-related neuropathology through pathways distinct from direct APOE effects, solidifying its potential as an etiologically informative biomarker.

Highlights

  • The association between APOE ε4 carriers and thinner RNFL was solidified by the J-T test and multiple linear regression, indicating genetic influence on retinal structure.
  • After inverse probability weighting adjustment, each 5-µm reduction in baseline RNFL thickness increased dementia risk by 15%, highlighting its long-term predictive value.
  • Only 7.6% of the effect of RNFL thickness on dementia risk was attributable to APOE status, underscoring the value of RNFL as a standalone, non-invasive biomarker in the assessment of long-term dementia risk.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
10.10
自引率
2.10%
发文量
134
审稿时长
10 weeks
期刊介绍: Alzheimer''s & Dementia: Translational Research & Clinical Interventions (TRCI) is a peer-reviewed, open access,journal from the Alzheimer''s Association®. The journal seeks to bridge the full scope of explorations between basic research on drug discovery and clinical studies, validating putative therapies for aging-related chronic brain conditions that affect cognition, motor functions, and other behavioral or clinical symptoms associated with all forms dementia and Alzheimer''s disease. The journal will publish findings from diverse domains of research and disciplines to accelerate the conversion of abstract facts into practical knowledge: specifically, to translate what is learned at the bench into bedside applications. The journal seeks to publish articles that go beyond a singular emphasis on either basic drug discovery research or clinical research. Rather, an important theme of articles will be the linkages between and among the various discrete steps in the complex continuum of therapy development. For rapid communication among a multidisciplinary research audience involving the range of therapeutic interventions, TRCI will consider only original contributions that include feature length research articles, systematic reviews, meta-analyses, brief reports, narrative reviews, commentaries, letters, perspectives, and research news that would advance wide range of interventions to ameliorate symptoms or alter the progression of chronic neurocognitive disorders such as dementia and Alzheimer''s disease. The journal will publish on topics related to medicine, geriatrics, neuroscience, neurophysiology, neurology, psychiatry, clinical psychology, bioinformatics, pharmaco-genetics, regulatory issues, health economics, pharmacoeconomics, and public health policy as these apply to preclinical and clinical research on therapeutics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信